You are here: Industry Insights > Takeda

News List

Numerate and Takeda Enter Drug Discovery Alliance contractpharma
June 14, 2017
Will generate novel clinical candidates using AI-driven drug discovery
New analyses support the effectiveness and safety of Entyvio (vedolizumab) pharmaasia
May 31, 2017
Data showcased at Digestive Disease Week (DDW) 2017 meeting include presentations of new analyses from the VICTORY consortium.
Takeda and GammaDelta Therapeutics announces collaboration pharmaasia
May 25, 2017
Takeda Pharmaceutical Company Limited and GammaDelta Therapeutics Ltd, an Abingworth portfolio company, announced that they have formed a strategic collaboration to develop GammaDelta Therapeutics’ novel T cell platform...
Takeda posts full-year profit growth despite lower revenue firstwordpharma
May 11, 2017
Takeda on Wednesday announced that its profit for the year ended March 31 climbed 43.4 percent versus the prior year to 114.9 billion yen ($1 billion). Meanwhile, revenue for the drugmaker fell 4.2 percent to 1.7 trillion yen ($14.9 billion).
Takeda Inks $100M Pact With GammaDelta contractpharma
May 10, 2017
Takeda and GammaDelta Therapeutics have formed a collaboration to develop GammaDelta Therapeutics' novel T cell platform, which is based on the unique properties of gamma delta (γδ) T cells derived from human tissues.
Takeda Announces FDA Accelerated Approval of Alunbrig americanpharmaceuticalreview
May 02, 2017
Takeda Pharmaceutical announced Alunbrig has received Accelerated Approval from the U.S. Food and Drug Administration (FDA) for the treatment of patients.
Takeda and Harrington Discovery Institute to Develop Rare Disease Therapeutics americanpharmaceuticalreview
April 28, 2017
Takeda Pharmaceutical and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio announced a multi-year collaboration to accelerate therapeutic discoveries in rare diseases.
Takeda enters into strategic collaboration with NuBiyota for Microbiome Therapeutics pharmaasia
April 18, 2017
Takeda Pharmaceutical Company Limited announced a strategic collaboration with NuBiyota LLC for the development of Microbial Ecosystem Therapeutic products.
Takeda and MMV launch new programme to find lead compounds for malaria treatment pharmaceutical-technology
April 06, 2017
Japanese-based Takeda Pharmaceutical Company and Medicines for Malaria Venture in Switzerland (MMV) have signed an agreement to start a new joint research programme aimed at finding lead compounds for malaria treatment.
Takeda lays off more than half of Ariad’s US staff pharmafile
April 01, 2017
the job cuts have begun – with Takeda having shed 180 staff from a total of nearly 300 members of staff from Ariad’s US operations.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page